Annals of Thoracic Surgery |

Popular Keywords

Benign Esophageal Diseases

Benign Lung Tumors

Chest Reconstruction

Chest Wall Tumors

Diaphragm Paralysis

Emphysema

Treatment with Multiple Modalities for T4 N2 Non-Small Cell Lung Cancer Including Ipsilateral Pulmonary Nodules

Correspondence to Author: Arvnd Kumar

Arvnd Kumar. Icahn School of Medicine at Mount Sinai, New York, New York.

Abstract: : It is difficult to determine the best course of action for T4 non-small cell lung cancer (NSCLC) with extra intrapulmonary nodules in a different ipsilateral lobe (T4- Add) across clinical N stages. In contrast to contemporaneous chemoradiation, this study assessed the long-term survival of patients with T4-Add N2 NSCLC who had multimodal therapy, which included chemotherapy and surgical resection.
The National Cancer Database’s T4-Add N2 M0 NSCLC patients from 2010 to 2015 were included.Using Kaplan-Meier analysis and Cox proportional hazards, long-term survival was assessed and compared between patients who underwent main site surgical resection with chemotherapy and those who received concomitant chemoradiation.propensity score matching and modeling on nine common prognostic factors, including comorbidities.

Citation:

Arvnd Kumar. Treatment with Multiple Modalities for T4 N2 Non-Small Cell Lung Cancer Including Ipsilateral Pulmonary Nodules . Annals of Thoracic Surgery 2024.